Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2025-12-25 @ 1:28 PM
NCT ID:
NCT01524692
Group ID:
EG000
Title:
Single ARM Dovitinib Treatment
Description:
Single ARM Dovitinib treatment
Dovitinib (TKI258): 500 mg orally on a 5-days on/2-days off schedule each week of a 4-week (28-day) cycle. Treatment will continue until progression as defined by RECIST, unacceptable adverse events, patient refusal to continue on study, or physician's decision to withdraw the patient.
Deaths Number Affected:
16
Deaths Number At Risk:
None
Serious Number Affected:
22
Serious Number At Risk:
35
Other Number Affected:
31
Other Number At Risk:
35
Study:
NCT01524692
Results Section:
NCT01524692
Adverse Events Module:
NCT01524692